Multiple sclerosis (MS) is universally found to be more prevalent in women than men. This
has led to extensive studies of differences in the immune system or nervous system between …

Current research efforts on neurological diseases are focused on identifying novel disease
biomarkers to aid in diagnosis, provide accurate prognostic information and monitor disease …

Background A female/male (F/M) ratio increase over time in multiple sclerosis (MS) patients
was demonstrated in many countries around the world. So far, a direct comparison of sex …

Multiple sclerosis (MS) is a common, complex neurological disease. Epidemiological data
implicate both genetic and environmental factors in the etiology of MS, with various factors …

Multiple sclerosis (MS) is the most common acquired inflammatory demyelinating disorder of
the central nervous system (CNS). Not unlike many inflammatory diseases with a presumed …

The number of people diagnosed with neurodegenerative diseases is on the rise. Many of
these diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and …

This review summarizes and integrates research on vitamin D and CD4+ T-lymphocyte
biology to develop new mechanistic insights into the molecular etiology of autoimmune …

As the most common non-traumatic disabling disease among adolescents, multiple sclerosis
(MS) is a devastating neurological inflammatory disease of the central nervous system …

Background: The prevalence of multiple sclerosis (MS) is not uniform, with a latitudinal
gradient of prevalence present in most studies. Understanding the drivers of this gradient …

Multiple sclerosis is a common and frequently disabling neurological disease of young
adults. It is characterised by recurrent areas of focal inflammation (plaques) in the CNS …